Free CPD Webinar to Explore Red-Light Therapy as Innovative Treatment for Myopia
Sydney, November 2024 – As the prevalence of myopia continues to increase across all age groups in Australia, optometrists are on the lookout for advanced, non-invasive treatments to manage its progression. In response, an upcoming Continuing Professional Development (CPD) webinar will delve into the global application of repeated low-level red-light therapy as a promising approach to myopia management. Scheduled for 20 November 2024, this session provides a timely and essential learning opportunity for practitioners seeking to expand their knowledge on emerging therapeutic options.
Addressing the Myopia Epidemic with Non-Invasive Solutions
Myopia rates have surged in recent years, with growing concern among optometrists and healthcare providers about the implications for long-term eye health. Red-light therapy, a treatment that has shown potential in slowing myopic progression, is drawing attention due to its non-invasive nature and accessibility. This webinar is set to provide attendees with a comprehensive overview of how repeated low-level red-light therapy is being implemented in clinical settings worldwide, exploring both its effectiveness and patient outcomes.
Insights from Global Clinical Experiences
Hosted by an expert panel, the CPD session will cover the latest research findings, examining how red-light therapy is being utilised in various countries. The discussion will include:
Mechanisms of Action: An overview of how red-light therapy works to potentially influence eye growth and control myopia progression.
Clinical Outcomes: Real-world data and case studies from practices using red-light therapy, highlighting observed effects on myopic children and adolescents.
Patient Experiences and Compliance: Insights into patient receptiveness to this treatment, especially among paediatric and adolescent groups, as well as strategies for improving compliance with treatment regimens.
This webinar is designed to equip optometrists with practical knowledge that they can integrate into their practice, especially as demand grows for myopia control solutions that go beyond conventional approaches like corrective lenses and atropine therapy.
The Importance of Staying Informed
As the landscape of myopia management evolves, optometrists have a crucial role in staying informed on new treatment modalities that support better patient outcomes. The CPD-accredited session not only provides valuable clinical insights but also counts towards optometrists’ annual CPD requirements, ensuring participants gain both professional development credits and actionable knowledge.
Register Now
The free webinar on 20 November 2024 offers an invaluable opportunity for Australian optometrists to learn about red-light therapy’s potential benefits and application in managing myopia. With spaces limited, optometrists are encouraged to register early to secure their place and engage with industry peers in exploring this innovative approach to myopia management.
For more information on registration and the session agenda, please visit the Optometry Australia website or your CPD portal.